From the GSE21359 discovery dataset of the COPD patients and the control samples, a nomogram integrated with the expression levels of key genes CBR1 and PRDX1 was constructed to quantify their clinical utility in predicting COPD risk (Figure 5A). Here, PRDX1 is linked to chronic obstructive pulmonary disease.